Regulations are stifling development of new drugsBMJ 2004; 328 doi: http://dx.doi.org/10.1136/bmj.328.7440.600-a (Published 11 March 2004) Cite this as: BMJ 2004;328:600
- Zosia Kmietowicz
The volumes of regulations that surround scientific research are stifling the development of new drugs and need to be rationalised if innovative discoveries in biology are to be matched with new medicines and demand by patients for better treatments, said experts this week.
It costs an estimated $800m (£433m; €645m) to get a new drug to the market, and pharmaceutical companies have to hit …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial